单孔腔镜前哨淋巴结活检联合吲哚菁绿与碳纳米混悬液在乳腺癌中的应用
本研究为回顾性观察性研究,每组20例、总样本60例,比较单孔腔镜前哨淋巴结活检联合吲哚菁绿与碳纳米混悬液、单孔腔镜联合碳纳米混悬液、传统开放联合吲哚菁绿与碳纳米混悬液三种方法。结果显示三组前哨淋巴结检出率分别为100%、100%、95%,上肢功能与疼痛评分无显著差异。新术式检出率与平均前哨淋巴结数与传统开放手术相似,且仅需腋窝单孔即可完成乳腺手术与前哨淋巴结活检,兼具美学优势。
要点
- 单孔腔镜前哨淋巴结活检联合吲哚菁绿与碳纳米混悬液检出率达100%。
- 三组上肢功能与疼痛评分无显著差异,安全性相当。
- 新术式仅需腋窝单孔即可完成乳腺手术与前哨淋巴结活检,具美学优势。
核心结论
- 对于符合适应证的患者,单孔腔镜前哨淋巴结活检与传统开放前哨淋巴结活检同样安全可靠,且仅需一个切口,具有美学优势。
研究设计与样本
- 回顾性观察性研究,共60例,每组20例:组1为单孔腔镜前哨淋巴结活检联合吲哚菁绿与碳纳米混悬液,组2为单孔腔镜联合碳纳米混悬液,组3为传统开放联合吲哚菁绿与碳纳米混悬液。
主要发现
- 前哨淋巴结检出率组1为100%、组2为100%、组3为95%。
- 三组间上臂功能与疼痛评分无显著差异。
- 新术式的前哨淋巴结检出率与平均前哨淋巴结数与传统开放前哨淋巴结活检相似。
关键数值与推荐
- 前哨淋巴结检出率:组1 100%,组2 100%,组3 95%。
- 三组上臂功能与疼痛评分无显著差异。
临床怎么用
- 对符合适应证的患者,可采用单孔腔镜前哨淋巴结活检联合吲哚菁绿与碳纳米混悬液,在保证检出率与安全性的同时仅需腋窝单孔完成乳腺手术与前哨淋巴结活检。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In order to explore the surgical safety and the reliability of axillary staging of single-port endoscopic-sentinel lymph node biopsy, we combined it with indocyanine green that was excited by near-infrared fluorescence endoscopy and carbon nanoparticles as a tracer and compared this method to conventional open sentinel lymph node biopsy. METHODS: This is a retrospective and observational study, there were 20 patients in each group and the total sample size was 60: Group 1, single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles; Group 2, single-port endoscopic-sentinel lymph node biopsy with carbon nanoparticles only; Group 3, conventional sentinel lymph node biopsy with indocyanine green and carbon nanoparticles. Sentinel lymph node detection and upper extremity function were determined to measure the safety and efficacy of the novel single-port endoscopic-sentinel lymph node biopsy (SPE-SLNB) technique to the standard conventional sentinel lymph node biopsy technique. RESULTS: The detection rate of sentinel lymph nodes was 100% in Group 1, 100% in Group 2, and 95% in Group 3. There were no significant differences in upper arm function and pain scores between the three groups. CONCLUSION: The novel technique of combining indocyanine green and carbon nanoparticles with single-port endoscopic-sentinel lymph node biopsy achieved a similar detection rate and mean number of sentinel lymph nodes as conventional sentinel lymph node biopsy. Traditional open surgery requires two different incisions for breast surgery and SLNB. While the most important advantage of SPE-SLNB is that two procedures can be effectively performed through a single-port in the axilla Therefore, for patients who meet the indications, single-port endoscopic-sentinel lymph node biopsy is as safe and reliable as conventional sentinel lymph node biopsy but has the aesthetic advantage of only one incision.
引用
- Wang ZH, Gang TR, Wu SS, et al. Single-port endoscopic-sentinel lymph node biopsy combined with indocyanine green and carbon nanoparticles in breast cancer. Surg Endosc. 2023. PMID: 37460818. doi:10.1007/s00464-023-10018-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。